Shares of Centene Corporation (NYSE:CNC – Get Free Report) have received an average rating of “Hold” from the twenty ratings firms that are currently covering the firm, MarketBeat reports. Three analysts have rated the stock with a sell recommendation, fourteen have assigned a hold recommendation and three have issued a buy recommendation on the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $38.4375.
Several equities analysts have recently issued reports on the stock. Zacks Research upgraded shares of Centene from a “strong sell” rating to a “hold” rating in a report on Wednesday, October 29th. Truist Financial restated a “buy” rating and set a $45.00 price target (up previously from $42.00) on shares of Centene in a research note on Thursday, October 30th. Oppenheimer reaffirmed an “outperform” rating and issued a $45.00 price target on shares of Centene in a report on Thursday, October 30th. Sanford C. Bernstein reissued an “outperform” rating and issued a $45.00 target price (up from $36.00) on shares of Centene in a research report on Friday, November 21st. Finally, UBS Group set a $42.00 target price on Centene and gave the stock a “neutral” rating in a report on Thursday, October 30th.
View Our Latest Research Report on Centene
Institutional Trading of Centene
Centene Stock Performance
Shares of CNC stock opened at $39.58 on Wednesday. The company has a quick ratio of 1.08, a current ratio of 1.08 and a debt-to-equity ratio of 0.83. The firm has a market cap of $19.46 billion, a price-to-earnings ratio of -3.66, a PEG ratio of 1.33 and a beta of 0.48. The company’s 50 day moving average is $37.18 and its 200 day moving average is $35.92. Centene has a 52-week low of $25.08 and a 52-week high of $66.81.
Centene (NYSE:CNC – Get Free Report) last released its quarterly earnings results on Wednesday, October 29th. The company reported $0.50 EPS for the quarter, beating the consensus estimate of ($0.21) by $0.71. The business had revenue of $49.69 billion during the quarter, compared to analyst estimates of $47.50 billion. Centene had a negative net margin of 2.85% and a positive return on equity of 7.82%. The company’s quarterly revenue was up 18.2% on a year-over-year basis. During the same period in the prior year, the firm posted $1.62 earnings per share. On average, sell-side analysts anticipate that Centene will post 6.86 EPS for the current fiscal year.
Centene Company Profile
Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.
Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.
See Also
- Five stocks we like better than Centene
- The boring AI play that could pay up to $4,290 monthly
- Put $1,000 into this stock by Jan 1 [Not NVDA]
- Trump’s “real estate deal for America” explained
- A month before the crash
- Trump Did WHAT??
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
